BioLife Solutions Inc  

(Public, NASDAQ:BLFS)   Watch this stock  
Find more results for BLFS
-0.12 (-2.09%)
Jan 19 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 5.55 - 5.73
52 week 1.71 - 7.53
Open 5.70
Vol / Avg. 0.00/59,987.00
Mkt cap 76.60M
P/E     -
Div/yield     -
EPS -0.42
Shares 13.63M
Beta 0.27
Inst. own 10%
Jan 4, 2018
Q4 2017 BioLife Solutions Inc Earnings Release
Nov 9, 2017
Q3 2017 BioLife Solutions Inc Earnings Call
Nov 9, 2017
Q3 2017 BioLife Solutions Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '17) 2016
Net profit margin -10.76% -97.74%
Operating margin -1.09% -58.97%
EBITD margin - -54.50%
Return on average assets -14.73% -79.24%
Return on average equity -24.29% -117.78%
Employees 35 -
CDP Score - -


3303 Monte Villa Pkwy Ste 310
BOTHELL, WA 98021-6200
United States - Map
+1-425-4011400 (Phone)
+1-425-4021433 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


BioLife Solutions, Inc. (BioLife) is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers. The Company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs; generic blood stem cell freezing and cell thawing media products; custom product formulation and custom packaging services; cold chain logistics services incorporating precision thermal packaging products and cloud-hosted Web applications, and contract aseptic manufacturing formulation, fill and finish services of liquid media products. Its products include HypoThermosol FRS, CryoStor, BloodStor, Cell Thawing Media, PrepaStor and biologistex cold-chain management service.

Officers and directors

Raymond Wayne Cohen Independent Chairman of the Board
Age: 58
Bio & Compensation  - Reuters
Michael Rice President, Chief Executive Officer, Chief Accounting Officer, Director
Age: 53
Bio & Compensation  - Reuters
Roderick de Greef Chief Financial Officer, Secretary
Age: 56
Bio & Compensation  - Reuters
Aby J. Mathew Ph.D. Senior Vice President, Chief Technology Officer
Age: 44
Bio & Compensation  - Reuters
Karen A Foster Vice President - Operations
Bio & Compensation  - Reuters
James Mathers Vice President of Sales
Bio & Compensation  - Reuters
Todd Berard Vice President - Marketing
Age: 47
Bio & Compensation  - Reuters
Thomas Girschweiler Independent Director
Age: 58
Bio & Compensation  - Reuters
Andrew G. Hinson Independent Director
Age: 53
Bio & Compensation  - Reuters
Joseph Schick Independent Director
Age: 54
Bio & Compensation  - Reuters